Von Hippel-Lindau disease
Other Names for this Disease
- Familial cerebelloretinal angiomatosis
- Lindau disease
- VHL syndrome
- Von Hippel-Lindau disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Tests & Diagnosis
The diagnosis of Von Hippel-Lindau (VHL) disease is suspected in individuals with characteristic lesions with hemangioblastomas, renal cysts, and renal cell carcinoma, pheochromocytoma, and endolymphatic sac tumors. VHL is the only gene known to be associated with VHL disease. Molecular genetic testing of the VHL gene detects mutations in nearly 100% of individuals with the disease. Such testing is clinically available.
Last updated: 5/20/2013
- Frantzen C, Links TP, and Giles RH. Von Hippel-Lindau Disease. GeneReviews. 06/21/2012; http://www.ncbi.nlm.nih.gov/books/NBK1463/. Accessed 6/9/2015.
- The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.